PMS-TOFACITINIB

Identification of Pms-Tofacitinib

No description

Google image searchProduct monograph

Active ingredient

tofacitinib (tofacitinib citrate), 5 MG

DIN: 02522799

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: PHARMASCIENCE INC

Date: 25-NOV-2022

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AF — Janus-associated kinase (JAK) inhibitors (ATC, ATC/DDD)
• L04AF01 — TOFACITINIB (ATC/DDD)

External Links for Pms-Tofacitinib

Search on Google

• Pms-Tofacitinib side effects
• Pms-Tofacitinib dosage
• tofacitinib side effects
• tofacitinib dosage

Pharmascience Inc

Go to Pharmascience website to see drug product details. Sometimes you can find pms-tofacitinib photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.